Skip to content

INVO Fertility, Inc.: 10-Q filed 2023-08-14

What INVO Fertility, Inc. reported in its quarterly report filed 2023-08-14 (fiscal Q2 2023): 43 published measures, 115 facts as tagged in accession 0001493152-23-028437.

This filing

Form
10-Q (quarterly report)
Filed
2023-08-14
Fiscal period
fiscal Q2 2023
Accession
0001493152-23-028437 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INVO Fertility, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-06-306,638,894USD
At 2022-12-314,103,715USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2023-06-308,344,388USD
At 2022-12-315,081,327USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-06-30-1,705,494USD
At 2022-12-31-977,612USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,240,511USD91
2023-01-01 to 2023-06-30-4,791,390USD181
2022-04-01 to 2022-06-30-2,801,541USD91
2022-01-01 to 2022-06-30-5,575,853USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-2,792,860USD181
2022-01-01 to 2022-06-30-3,950,920USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2023-01-01 to 2023-06-30261,505USD181
2022-01-01 to 2022-06-308,338USD181

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2023-04-01 to 2023-06-30315,902USD91
2023-01-01 to 2023-06-30663,927USD181
2022-04-01 to 2022-06-30146,135USD91
2022-01-01 to 2022-06-30308,733USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-01-01 to 2023-06-303,085,162USD181
2022-01-01 to 2022-06-30315,000USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-269,952USD181
2022-01-01 to 2022-06-30-86,792USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-06-30-54,574,923USD
At 2022-12-31-49,783,533USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-04-01 to 2023-06-30732,255shares91
2023-01-01 to 2023-06-30677,684shares181
2022-04-01 to 2022-06-30605,760shares91
2022-01-01 to 2022-06-30604,123shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2023-04-01 to 2023-06-30732,255shares91
2023-01-01 to 2023-06-30677,684shares181
2022-04-01 to 2022-06-30605,760shares91
2022-01-01 to 2022-06-30604,123shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3.06USD/shares91
2023-01-01 to 2023-06-30-7.07USD/shares181
2022-04-01 to 2022-06-30-4.62USD/shares91
2022-01-01 to 2022-06-30-9.23USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-3.06USD/shares91
2023-01-01 to 2023-06-30-7.07USD/shares181
2022-04-01 to 2022-06-30-4.62USD/shares91
2022-01-01 to 2022-06-30-9.23USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,865USD91
2023-01-01 to 2023-06-302,865USD181
2022-04-01 to 2022-06-30800USD91
2022-01-01 to 2022-06-30800USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-06-30659,442USD
At 2022-12-31436,729USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-01-01 to 2023-06-30652,750USD181
2022-01-01 to 2022-06-30861,284USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,065,977USD91
2023-01-01 to 2023-06-30-4,372,397USD181
2022-04-01 to 2022-06-30-2,681,821USD91
2022-01-01 to 2022-06-30-5,382,759USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-06-30842,125USD
At 2022-12-31621,087USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2023-04-01 to 2023-06-30175,192USD91
2023-01-01 to 2023-06-30391,781USD181
2022-04-01 to 2022-06-30102USD91
2022-01-01 to 2022-06-301,558USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-06-304,469,150USD
At 2022-12-313,409,424USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2023-06-3074,908USD
At 2022-12-3177,149USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,381,879USD91
2023-01-01 to 2023-06-305,036,324USD181
2022-04-01 to 2022-06-302,827,956USD91
2022-01-01 to 2022-06-305,691,492USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2023-06-30280,018USD
At 2022-12-31263,602USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2023-04-01 to 2023-06-302,042,609USD91
2023-01-01 to 2023-06-304,373,443USD181
2022-04-01 to 2022-06-302,444,586USD91
2022-01-01 to 2022-06-304,991,714USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2023-04-01 to 2023-06-3083,850USD91
2023-01-01 to 2023-06-30157,370USD181
2022-04-01 to 2022-06-30190,761USD91
2022-01-01 to 2022-06-30294,941USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-06-30826,886shares
At 2022-12-31608,611shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2023-06-30-1,705,494USD
At 2022-12-31-977,612USD
At 2022-06-303,356,425USD
At 2021-12-317,310,680USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2023-06-304,004,962USD
At 2022-12-311,808,034USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2023-06-304,100,315USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2023-06-30192,059USD
At 2022-12-31153,267USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-06-30374,714USD
At 2022-12-31190,201USD

Net deferred tax liabilities

Deferred tax liabilities net of related assets under this concept. The amount reflects timing differences and is not tax currently due.

PeriodValueUnitDays
At 2023-06-301,949USD
At 2022-12-311,949USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-2,237,646USD91
2023-01-01 to 2023-06-30-4,788,525USD181
2022-04-01 to 2022-06-30-2,800,741USD91
2022-01-01 to 2022-06-30-5,575,053USD181

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-4,791,390USD181
2022-01-01 to 2022-06-30-5,575,853USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2023-04-01 to 2023-06-3019,705USD91
2023-01-01 to 2023-06-3038,792USD181
2022-04-01 to 2022-06-3021,630USD91
2022-01-01 to 2022-06-3036,725USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2023-01-01 to 2023-06-3038,792USD181
2022-01-01 to 2022-06-3037,629USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-04-01 to 2022-06-30452USD91
2022-01-01 to 2022-06-30904USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2023-04-01 to 2023-06-30-171,669USD91
2023-01-01 to 2023-06-30-416,128USD181
2022-04-01 to 2022-06-30-118,920USD91
2022-01-01 to 2022-06-30-192,294USD181

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-01-01 to 2023-06-305,720USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2022-01-01 to 2022-06-302,847USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-06-302,728,938USD181
2022-01-01 to 2022-06-30315,000USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-06-30-2,241USD181
2022-01-01 to 2022-06-306,015USD181

Inspect the source

Entity
INVO Fertility, Inc. / CIK 0001417926
Captured
2026-09-20T08:02:38.408Z
SEC response SHA-256
685ad9dc506bdfe829560566a030c772be69de24616cba6e2a255a48eadc071b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001417926.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))